BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22612236)

  • 41. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
    Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
    Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.
    Lin MC; Fu YC; Jan SL; Lin WW; Chu KH; Ting CT; Chen YT; Chi CS
    Acta Paediatr Taiwan; 2005; 46(1):17-23. PubMed ID: 16302572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
    Pedra CA; Pedra SF; Costa RN; Ribeiro MS; Nascimento W; Campanhã LO; Santana MV; Jatene IB; Assef JE; Fontes VF
    J Interv Cardiol; 2016 Apr; 29(2):208-15. PubMed ID: 26927945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
    Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
    Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
    Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follow-up results of transcatheter occlusion of atrial septal defects with buttoned device.
    Rao PS; Ende DJ; Wilson AD; Smith PA; Chopra PS
    Can J Cardiol; 1995 Sep; 11(8):695-701. PubMed ID: 7671179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adults.
    Cansel M; Pekdemir H; Yağmur J; Tasolar H; Ermis N; Kurtoglu E; Acıkgoz N; Atas H; Ozdemir R
    Arch Cardiovasc Dis; 2011 Mar; 104(3):155-60. PubMed ID: 21497304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.
    Toggweiler S; Moccetti F; Conrad N; Loretz L; Madanchi M; Bossard M; Attiger-Toller A; Cuculi F; Wolfrum M
    J Invasive Cardiol; 2024 Apr; 36(4):. PubMed ID: 38412438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intermediate and long-term outcome of patients after device closure of ASD with special reference to complications.
    Kazmi T; Sadiq M; Asif-ur-Rehman ; Hyder N; Latif F
    J Ayub Med Coll Abbottabad; 2009; 21(3):117-21. PubMed ID: 20929028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Closure of secundum atrial septal defects by the Amplatzer occluder device].
    Yüce M; Ozer O; Cakıcı M; Sarı I; Davutoğlu V; Doğan A; Alıcı H; Yavuz F; Aksoy M
    Turk Kardiyol Dern Ars; 2011 Jan; 39(1):35-40. PubMed ID: 21358229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.
    Haas NA; Soetemann DB; Ates I; Baspinar O; Ditkivskyy I; Duke C; Godart F; Lorber A; Oliveira E; Onorato E; Pac F; Promphan W; Riede FT; Roymanee S; Sabiniewicz R; Shebani SO; Sievert H; Tin D; Happel CM
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):571-581. PubMed ID: 27029396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.
    Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
    J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A; Shen R; Silvestry FE; Herrmann HC
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1066-9. PubMed ID: 19670302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcatheter device occlusion of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance.
    Salomé N; Braga P; Gonçalves M; Rodrigues A; Ribeiro J; Fonesca C; Pinto F; Ribeiro VG
    Rev Port Cardiol; 2004 May; 23(5):709-17. PubMed ID: 15279455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
    Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
    J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.